Your session is about to expire
← Back to Search
Post-Discharge Education for Sepsis Readmission Prevention
N/A
Waitlist Available
Led By Nancy Bickel, MSN, APRN, ANCP-BC, ACNS-BC
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
Study Summary
This trial tests how well patient education and home-based interventions can prevent sepsis readmission. It may be the first of many studies to come. #patienteducation #sepsisreadmission
Who is the study for?
This trial is for English-speaking oncology patients aged 18-85 who have been diagnosed with sepsis, severe sepsis, or septic shock and are discharged home. They must own a mobile phone/device. It excludes non-English speakers, non-oncology patients, those outside the age range, without a diagnosis of sepsis-related conditions, or without a mobile device.Check my eligibility
What is being tested?
The study tests if post-discharge education can prevent new infections and reduce readmissions in sepsis patients. It explores whether innovative teaching methods via mobile devices impact patient outcomes and could lead to more studies based on its findings.See study design
What are the potential side effects?
Since this intervention involves educational content delivered through a mobile device rather than medication or medical procedures, traditional side effects are not applicable. However, participants may experience stress or anxiety from the information provided.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Readmission rates
Trial Design
1Treatment groups
Experimental Treatment
Group I: Sepsis EducationExperimental Treatment1 Intervention
The patient will receive a daily notification via their mobile phone and conduct the daily activity for 30 days. The program is interactive and aimed at measures that prevent exposure to infection sources in the environment, as well as recognition of early signs of infection and possible sepsis. Each session takes approximately 2 minutes or less. Each scenario or session has the user identify where germs may be present and then asks the user to perform a simple action to remove the germs (e.g. with an antiseptic wipe). The range of activities include cleaning of surfaces, proper mask use, and hand sanitizing. This includes areas of their home such as the kitchen, bathroom, living room/family room. The program also addresses common community areas such as public transit, grocery stores, and restaurants
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,931 Previous Clinical Trials
2,299,609 Total Patients Enrolled
9 Trials studying Sepsis
21,416 Patients Enrolled for Sepsis
BJC HealthCareUNKNOWN
3 Previous Clinical Trials
46,682 Total Patients Enrolled
Viven HealthUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 85 years old.I was sent home after being treated for a severe infection.I have not been diagnosed with sepsis or severe infections.I speak English.I am younger than 18 or older than 85.I do not have cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Sepsis Education
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What prerequisites must potential participants meet to be eligible for enrollment in this research study?
"This clinical trial, which has a target enrolment of 100 patients, requires applicants to have pyemia and be within the age bracket of 18-85."
Answered by AI
Is this experiment currently recruiting participants?
"As per clinicaltrials.gov, this particular medical trial is not actively seeking participants at the moment; although it was posted on December 31st 2022 and updated as recently October 27th 2022. Fortunately, there are 170 other trials scouring for eligible patients currently in progress."
Answered by AI
Are participants aged seventy-five and below eligible for inclusion in this trial?
"This clinical trial requires that all prospective participants are aged between 18 and 85. Those younger than 18 can apply to 33 other medical studies, while those over 65 may consider the 146 trials available for them."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger